Accelerated Corneal Crosslinking for Treatment of Keratoconus in Children and Adolescents under 18 Years of Age

Abstract Purpose To evaluate the efficacy of accelerated (9 mW/cm 2 , 10 min) epithelium-off (epi-off) corneal crosslinking (A-CXL) in keratoconus (KC) patients < 18 years of age. Patients and Methods Our retrospective study included 41 eyes (25 male and 5 female patients, mean age 15.3 ± 1.2 years) who underwent A-CXL (9 mW/cm 2 , 10 min) because of progressive KC or critical KC at first presentation or asymmetrical finding in the partner eye. Outcome measures were best-corrected visual acuity (BCVA) and tomography readings (Pentacam HR, Oculus, Wetzlar, Germany), evaluated 2 years, 1 year, 6 months preoperatively, prior to surgery (pre-CXL) and 6 weeks, 6 months, 1 year, 2 years, > 2 years postoperatively (post-CXL). The demarcation line was assessed by anterior segment optical coherence tomography (SS-1000 and CASIA 2, Tomey, Nagoya, Japan). Results Total deviation value increased statistically significantly 6 months pre-CXL to pre-CXL. Anterior steep, flat, and mean keratometry values showed a statistically significant increase 6 weeks post-CXL (p < 0.05), followed by a significant decrease until 2 years post-CXL for steep and mean keratometry. K max increased 6 weeks post-CXL without statistical significance and decreased significantly even > 2 years post-CXL (p < 0.0001). Posterior keratometry as well as anterior and posterior astigmatism did not show any significant changes post-CXL. Thinnest and apical pachymetry decreased significantly until 6 months post-CXL (p < 0.05) and remained stable > 2 years post-CXL (p > 0.05). BCVA decreased 6 weeks post-CXL but improved significantly > 2 years post-CXL (p = 0.003). The demarcation line reached an average depth of 52.1%. Conclusions Epi-off A-CXL stabilizes KC progression in patients < 18 years even > 2 years postoperatively and leads to a deep demarcation line. A “pseudoprogression” is observed up to the 6-week follow-up, which is not indicative of the long-term results.

[1]  R. Tandon,et al.  Pediatric keratoconus - Current perspectives and clinical challenges , 2021, Indian journal of ophthalmology.

[2]  B. Seitz,et al.  Keratoconus staging by decades: a baseline ABCD classification of 1000 patients in the Homburg Keratoconus Center , 2020, British Journal of Ophthalmology.

[3]  A. Rednik,et al.  Comparative Results of “Epi-Off” Conventional versus “Epi-Off” Accelerated Cross-Linking Procedure at 5-year Follow-Up , 2020, Journal of ophthalmology.

[4]  L. Buzzonetti,et al.  Keratoconus in Children: A Literature Review. , 2020, Cornea.

[5]  N. G. Yalcin,et al.  Accelerated epithelium-on or accelerated epithelium-off corneal collagen cross-linking: Contralateral comparison study , 2020, Taiwan journal of ophthalmology.

[6]  Elsie Chan,et al.  Optimal management of pediatric keratoconus: challenges and solutions , 2019, Clinical ophthalmology.

[7]  I. Avni,et al.  Corneal Cross-Linking in Pediatric Patients: Evaluating Treated and Untreated Eyes—5-Year Follow-Up Results , 2018, Cornea.

[8]  T. Kohnen,et al.  Evaluation of keratoconus progression , 2018, British Journal of Ophthalmology.

[9]  Y. Rabinowitz,et al.  Corneal Cross-Linking for Pediatric Keratcoconus Review , 2018, Cornea.

[10]  C. Mazzotta,et al.  Corneal Collagen Cross-Linking With Riboflavin and Ultraviolet A Light for Pediatric Keratoconus: Ten-Year Results , 2018, Cornea.

[11]  B. Ambati,et al.  Pediatric keratoconus: a review of the literature , 2018, International Ophthalmology.

[12]  A. Badawi Accelerated corneal collagen cross-linking in pediatric keratoconus: One year study , 2017, Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society.

[13]  P. Padmanabhan,et al.  Corneal Collagen Cross-Linking for Keratoconus in Pediatric Patients-Long-Term Results. , 2017, Cornea.

[14]  Ö. Uçakhan,et al.  Pediatric Corneal Collagen Cross-Linking: Long-Term Follow-Up of Visual, Refractive, and Topographic Outcomes , 2016, Cornea.

[15]  L. Laroche,et al.  Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis. , 2015, Journal of visualized experiments : JoVE.

[16]  C. Jayadev,et al.  Current Protocols of Corneal Collagen Cross-Linking: Visual, Refractive, and Tomographic Outcomes. , 2015, American journal of ophthalmology.

[17]  E. Toker,et al.  Transepithelial versus epithelium‐off crosslinking in adults with progressive keratoconus , 2015, Journal of cataract and refractive surgery.

[18]  M. O'Keefe,et al.  Corneal collagen crosslinking in children with keratoconus. , 2015, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[19]  R. Wisse,et al.  Transepithelial versus epithelium-off corneal cross-linking for the treatment of progressive keratoconus: a randomized controlled trial. , 2015, American journal of ophthalmology.

[20]  C. Jayadev,et al.  Accelerated Corneal Collagen Cross-Linking in Pediatric Patients: Two-Year Follow-Up Results , 2014, BioMed research international.

[21]  A. Salman Transepithelial corneal collagen crosslinking for progressive keratoconus in a pediatric age group , 2013, Journal of cataract and refractive surgery.

[22]  A. Fotouhi,et al.  Corneal collagen cross-linking with riboflavin and ultraviolet a irradiation for keratoconus: long-term results. , 2013, Ophthalmology.

[23]  Sundaram Natarajan,et al.  Keratoconus , 2013, Indian journal of ophthalmology.

[24]  C. Mazzotta,et al.  Transepithelial corneal collagen crosslinking for progressive keratoconus: 24‐month clinical results , 2013, Journal of cataract and refractive surgery.

[25]  F. Hafezi,et al.  Progression of keratoconus and efficacy of pediatric [corrected] corneal collagen cross-linking in children and adolescents. , 2012, Journal of refractive surgery.

[26]  R. Arora,et al.  Results of corneal collagen cross-linking in pediatric patients. , 2012, Journal of refractive surgery.

[27]  P. Vinciguerra,et al.  Two-year corneal cross-linking results in patients younger than 18 years with documented progressive keratoconus. , 2012, American journal of ophthalmology.

[28]  J. Colin,et al.  Scalability and severity of keratoconus in children. , 2012, American journal of ophthalmology.

[29]  C. Mazzotta,et al.  Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. , 2010, American journal of ophthalmology.

[30]  R. Vinciguerra,et al.  Refractive, topographic, tomographic, and aberrometric analysis of keratoconic eyes undergoing corneal cross-linking. , 2009, Ophthalmology.

[31]  A. Ertan,et al.  Keratoconus Clinical Findings According to Different Age and Gender Groups , 2008, Cornea.

[32]  Xiaohui Li,et al.  Longitudinal study of keratoconus progression. , 2007, Experimental eye research.

[33]  M. Gordon,et al.  Baseline factors predictive of incident penetrating keratoplasty in keratoconus. , 2006, American journal of ophthalmology.

[34]  M. Gordon,et al.  Estimation of the incidence and factors predictive of corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. , 2006, Cornea.

[35]  M. Gordon,et al.  Estimation of the Incidence and Factors Predictive of Corneal Scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study , 2006 .

[36]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.

[37]  T T McMahon,et al.  Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. , 1998, Investigative ophthalmology & visual science.

[38]  Joseph T. Barr,et al.  Biomicroscopic Signs and Disease Severity in Keratoconus , 1996 .